InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-08-13 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-08-05 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| 2025-07-10 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| 2025-06-24 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| 2025-05-30 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Premiums | $164.64B+14.2% | $144.17B+0.9% | $142.85B+7.2% | $133.23B+13.5% | $117.37B |
| Total operating revenue | $197.58B+12.8% | $175.20B+2.9% | $170.21B+9.3% | $155.66B+13.7% | $136.94B |
| Net investment income | $2.19B+7.0% | $2.05B+12.4% | $1.82B+22.9% | $1.49B+7.8% | $1.38B |
| Net losses on financial instruments | -$653.0M-46.7% | -$445.0M+35.9% | -$694.0M-26.2% | -$550.0M | — |
| Gain on sale of business | $0-100.0% | $201.0M | $0 | $0 | — |
| Total revenues | $199.13B+12.5% | $177.01B+3.3% | $171.34B+9.4% | $156.59B+13.0% | $138.64B |
| Benefit expense | $148.22B+16.2% | $127.57B+2.6% | $124.33B+6.6% | $116.64B+13.7% | $102.57B |
| Cost of products sold | $21.18B+7.2% | $19.75B+14.2% | $17.29B+32.7% | $13.04B+19.6% | $10.89B |
| Operating expense | $20.98B+4.8% | $20.02B-0.3% | $20.09B+13.5% | $17.70B+11.2% | $15.92B |
| Interest expense | $1.40B+18.3% | $1.19B+15.0% | $1.03B+21.0% | $851.0M+6.6% | $798.0M |
| Amortization of other intangible assets | $628.0M+8.3% | $580.0M-34.5% | $885.0M+15.4% | $767.0M+73.9% | $441.0M |
| Total expenses | $192.41B+13.8% | $169.11B+3.4% | $163.63B+9.8% | $149.00B+14.0% | $130.64B |
| Income before income tax expense | $6.71B-15.1% | $7.90B+2.4% | $7.71B+1.5% | $7.60B-4.9% | $8.00B |
| Income tax expense | $1.05B-45.7% | $1.93B+12.1% | $1.72B+0.7% | $1.71B-7.3% | $1.85B |
| Net income | $5.66B-5.2% | $5.97B-0.3% | $5.99B+1.7% | $5.89B | — |
| Net loss (gain) attributable to noncontrolling interests | $1.0M-88.9% | $9.0M+325.0% | -$4.0M-166.7% | $6.0M | — |
| Shareholders’ net income | $5.66B-5.3% | $5.98B-0.1% | $5.99B+1.6% | $5.89B | — |
| Basic (in dollars per share) | $25.3M-2.1% | $25.8M+1.7% | $25.4M+3.3% | $24.6M | — |
| Diluted (in dollars per share) | $25.2M-1.8% | $25.7M+1.8% | $25.2M+3.9% | $24.3M | — |
| Product revenue | |||||
| Product and service revenue | $8.47B+0.8% | $8.41B+6.4% | $7.90B+6.0% | $7.45B | — |
| Service fees | |||||
| Product and service revenue | $8.47B+0.8% | $8.41B+6.4% | $7.90B+6.0% | $7.45B | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Cigna Q1 Earnings Beat Estimates on Strong Evernorth Unit
NovoCure Q1 Earnings Call Highlights
Elevance Health’s Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small Businesses
The Medicaid Pain Is Ending. Buy Elevance Health and These 2 Stocks.